Prevalence and genetic characterization of blaCTX-M among Klebsiella pneumoniae isolates collected in an intensive care unit in Brazil

Journal of Chemotherapy

Volumn 20, Issue 5, 2008, Pages 600-603

  Do Carmo Filho, J R ^a   Silva, R M ^b   Castanheira, Mariana ^c   Tognim, M C B ^d   Gales, A C ^b   Sader, H S ^b,c  

^a PONTIFÍCIA UNIVERSIDADE CATÓLICA DE GOIÁS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c JMI LABORATORIES   (United States)

^d STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Antimicrobial resistance; Extended spectrum beta lactamases; Genetic resistance mechanisms; Klebsiella pneumoniae

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE CTX M 2; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; GATIFLOXACIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BRAZIL; CLUSTER ANALYSIS; DISEASE SEVERITY; DRUG POTENTIATION; ENTEROBACTER INFECTION; GENETIC RESISTANCE; HUMAN; INTEGRON; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PREVALENCE; TERTIARY HEALTH CARE;

EID: 57049159995     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.5.600     Document Type: Article

References (11)

1. Helfand MS, Bonomo RA. Extended-spectrum β-lactamases in multidrug-resistant Escherichia coli: Changing the therapy for hospital-acquired and community-acquired infections. Clin Infect Dis. 2006; 43 (11): 1415-6.
2. Bonnet R. Growing group of extended-spectrum β-lactamases: The CTX-M enzymes. Antimicrob Agents Chemother. 2004; 48 (1): 1-14.
3. Livermore DM, Canton R, Gniadkowski M, et al. CTX-M: Changing the face of ESBLs in Europe. J Antimicrob Chemother. 2007; 59 (2): 165-74.
4. CTX-M genes. J Antimicrob Chemother. 2006; 57 (1): 14-23.
5. Minarini LA, Gates AC, Palazzo IC, Darini AL. Prevalence of community-occurring extended spectrum β-lactamase-producing Enterobacteriaceae in Brazil. Curr Microbiol. 2007; 54 (5): 335-41.
6. Carter MW, Oakton KJ, Warner M, Livermore DM. Detection of extended-spectrum β-lactamases in Klebsiellae with the Oxoid combination disk method. J Clin Microbiol. 2000; 38 (11): 4228-32.
7. CLSI. Clinical and Laboratory Standards Institute. M7-A7, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - seventh edition. Wayne, PA: CLSI. 2006.
8. Platter MA, Hollis RJ, Sader HS. Chromosomal restriction fragment analysis by pulsed-field gel electrophoresis. In: Isenberg HD. Clinical Microbiology Procedures Handbook (Supplement 1). Washington, ASM Press, pp10.5.c. 1-10.5.c. 11. 1992.
9. Sambrook J, MacCallum P, Russell D. Molecular cloning: A laboratory manual, 3rd edition. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press; 2001.
10. Toleman MA, Bennett PM, Walsh TR. Common regions e.g. orf513 and antibiotic resistance: IS91-like elements evolving complex class 1 integrons. J Antimicrob Chemother. 2006; 58 (1): 1-6.
11. Canton R, Coque TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol. 2006; 9 (5): 466-75.